blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3285801

EP3285801 - NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.03.2019
Database last updated on 30.10.2024
FormerRequest for examination was made
Status updated on  26.01.2018
FormerThe international publication has been made
Status updated on  01.11.2016
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Immatics Biotechnologies GmbH
Paul-Ehrlich-Strasse 15
72076 Tübingen / DE
[2018/09]
Inventor(s)01 / MAHR, Andrea
Horemer 17
72076 Tübingen / DE
02 / WEINSCHENK, Toni
Im Morgenrain 15
73773 Aichwald / DE
03 / SCHOOR, Oliver
Eichhaldenstrasse 19
72074 Tübingen / DE
04 / FRITSCHE, Jens
Lärchenweg 11
72144 Dussilingen / DE
05 / SINGH, Harpreet
5122 Morningside Dr., Apt. 525
77005 Houston / US
06 / WAGNER, Claudia
Nürtinger Strasse 32
72074 Tübingen / DE
07 / LEIBOLD, Julia
Austrasse 8
6250 Kundl / AT
08 / SONG, Colette
Willi-Baumeister-Weg 21
73760 Ostfildern / DE
 [2020/45]
Former [2020/44]01 / MAHR, Andrea
Horemer 17
72076 Tübingen / DE
02 / WEINSCHENK, Toni
Im Morgenrain 15
73773 Aichwald / DE
03 / SCHOOR, Oliver
Eichhaldenstrasse 19
72074 Tübingen / DE
04 / FRITSCHE, Jens
Lärchenweg 11
72144 Dussilingen / DE
05 / SINGH, Harpreet
5122 Morningside Dr., Apt. 525
77005 Houston / US
06 / WAGNER, Claudia
Nürtinger Strasse 32
72074 Tübingen / DE
07 / LEIBOLD, Juli
Austrasse 8
6250 Kundl / AT
08 / SONG, Colette
Willi-Baumeister-Weg 21
73760 Ostfildern / DE
Former [2018/09]01 / MAHR, Andrea
Kirschenweg 22
72076 Tübingen / DE
02 / WEINSCHENK, Toni
Im Morgenrain 15
73773 Aichwald / DE
03 / SCHOOR, Oliver
Eichhaldenstrasse 19
72074 Tübingen / DE
04 / FRITSCHE, Jens
Lärchenweg 11
72144 Dussilingen / DE
05 / SINGH, Harpreet
5122 Morningside Dr., Apt. 525
77005 Houston / US
06 / WAGNER, Claudia
Nürtinger Strasse 32
72074 Tübingen / DE
07 / LEIBOLD, Juli
Austrasse 8
6250 Kundl / AT
08 / SONG, Colette
Willi-Baumeister-Weg 21
73760 Ostfildern / DE
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[N/P]
Former [2018/09]Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
Application number, filing date16717663.522.04.2016
[2018/09]
WO2016EP59053
Priority number, dateGB2015000703024.04.2015         Original published format: GB 201507030
US201562152258P24.04.2015         Original published format: US 201562152258 P
[2018/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016170139
Date:27.10.2016
Language:EN
[2016/43]
Type: A1 Application with search report 
No.:EP3285801
Date:28.02.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 27.10.2016 takes the place of the publication of the European patent application.
[2018/09]
Search report(s)International search report - published on:EP27.10.2016
(Supplementary) European search report - dispatched on:EP01.04.2019
ClassificationIPC:A61K39/00, C07K14/47
[2018/09]
CPC:
A61K39/0011 (EP,CN,IL,RU,US); A61K35/17 (EP,CN,IL,KR,RU,US); C07K14/4748 (EP,CN,IL,KR,RU,US);
C07K14/70539 (CN,IL,KR,RU,US); A61K39/4611 (EP,CN,IL,KR,RU,US); A61K39/4613 (KR);
A61K39/4615 (KR); A61K39/4632 (KR); A61K39/464499 (EP,CN,IL,KR,RU,US);
A61P35/00 (EP,CN,IL,KR,RU,US); A61P35/02 (CN,KR); C07K14/7051 (IL,RU,US);
C07K14/70514 (KR); C07K14/70517 (KR); C07K16/2833 (IL,KR,RU,US);
C07K16/30 (IL,KR,RU,US); C12N15/115 (KR,RU); C12N15/85 (CN);
C12N5/0636 (EP,CN,IL,KR,RU,US); C12N5/0638 (EP,CN,IL,RU,US); C12N5/0639 (EP,CN,IL,KR,RU,US);
C12Q1/6886 (IL,US); G01N33/57492 (IL,US); G16B20/20 (IL,US);
A61K2039/5154 (KR); A61K2039/804 (CN); A61K2039/812 (CN);
A61K2039/82 (CN); A61K2039/828 (CN); A61K2039/836 (CN);
A61K2039/844 (CN); A61K2039/852 (CN); A61K2039/86 (CN);
A61K2039/868 (CN); A61K2039/876 (CN); A61K2039/884 (CN);
A61K2039/892 (CN); A61K2239/31 (KR); A61K2239/46 (KR);
A61K2239/55 (KR); C07K2319/00 (CN,IL,US); C07K2319/30 (IL,US);
C07K2319/33 (IL,US); C07K2319/55 (IL,US); C07K2319/74 (IL,US);
C12N2310/16 (KR); C12N2501/50 (IL,US); C12N2510/00 (CN);
C12N2800/107 (CN); C12Q2600/106 (IL,US); C12Q2600/112 (IL,US);
C12Q2600/156 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/09]
Extension statesBA21.11.2017
ME21.11.2017
Validation statesMA21.11.2017
MD21.11.2017
TitleGerman:NEUARTIGE PEPTIDE UND KOMBINATION VON PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN LUNGENKREBS, EINSCHLIESSLICH NSCLC UND ANDERE KREBSERKRANKUNGEN[2018/09]
English:NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS[2018/09]
French:NOUVEAUX PEPTIDES ET COMBINAISON DE PEPTIDES À UTILISER DANS L'IMMUNOTHÉRAPIE DU CANCER DU POUMON, Y COMPRIS LE CPNPC ET D'AUTRES CANCERS[2018/09]
Entry into regional phase21.11.2017National basic fee paid 
21.11.2017Designation fee(s) paid 
21.11.2017Examination fee paid 
Examination procedure21.11.2017Examination requested  [2018/09]
21.11.2017Date on which the examining division has become responsible
13.06.2018Amendment by applicant (claims and/or description)
01.04.2019Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M06) [2019/18]
01.04.2019Despatch of a communication from the examining division (Time limit: M06)
01.10.2019Reply to a communication from the examining division
23.03.2020Despatch of a communication from the examining division (Time limit: M04)
02.06.2020Reply to a communication from the examining division
Divisional application(s)EP20179381.7  / EP3760225
EP20179382.5  / EP3750557
EP20179383.3  / EP3750558
EP20179384.1  / EP3750559
Fees paidRenewal fee
11.04.2018Renewal fee patent year 03
15.04.2019Renewal fee patent year 04
18.03.2020Renewal fee patent year 05
27.04.2021Renewal fee patent year 06
16.03.2022Renewal fee patent year 07
30.03.2023Renewal fee patent year 08
27.03.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]WO2009015842  (IMMATICS BIOTECHNOLOGIES GMBH [DE], et al);
 [X]WO2009075883  (UNIV GEORGIA RES FOUND [US], et al);
 [XY]WO2011113819  (IMMATICS BIOTECHNOLOGIES GMBH [DE], et al);
 [XYI]WO2011113882  (IMMATICS BIOTECHNOLOGIES GMBH [DE], et al);
 [X]WO2012100023  (UNIV JEFFERSON [US], et al);
 [I]WO2015018805  (IMMATICS BIOTECHNOLOGIES GMBH [DE]);
ExaminationEP1332760
 WO2009015842
 WO2015018805
 WO2017036936
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.